Boehringer Ingelheim Corporation Plans To Cut Up To 600 Jobs
Allergan Inc. (AGN) Rejected Actavis (ACT) Takeover Bid; In Advanced Talks To Buy Salix Pharmaceuticals, Ltd. (SLXP)
Allergan Inc. (AGN) Ordered To Show Business Strategy Documents
AstraZeneca PLC (AZN), Shire Shares Plummet On New U.S. Rules To Curb Tax-Inversion Deals
Swiss Biotech Firm Molecular Partners AG Plans $134 Million IPO
Amgen (AMGN) Submits Biologics License Application For Breakthrough Drug Blinatumomab
Viropro Inc. (VPRO) Subsidiary Alpha Biologics Sdn Bhd (ABSB)'s Assets Have Been Seized By A Bank In Malaysia
Departure Of Ariad Pharmaceuticals, Inc. (ARIA) Director Sparks Speculation That CEO Berger's Days Are Numbered
Novartis AG (NVS) Studies Muscle Atrophy By Sending Mice Into Space
Emergency Use Of Tekmira Pharmaceuticals Corporation (TKMR)'s Ebola Drug Cleared By FDA, Health Canada
Par Pharmaceutical, Inc. To Pay $100 Million To Settle Suit Over Generic Heartburn Drug
Merus Labs International Inc. CEO Steps Down: Interim Chief Named
San Diego-Based Cytori Therapeutics, Inc. (CYTX) Chops Staff, EVP Under Pressure From Lenders
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline
Bay Area's Dermira Supersizes IPO Up 30% To $98M
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL)
Auxilium Pharmaceuticals (AUXL) Rejects $2.2B Bid From Endo International plc (ENDP), While QLT Inc. (QLTI) Merger Looks More Likely
Avalon Ventures, GlaxoSmithKline (GSK) Bet $20M On Two Biotech Startups
See All News >